Mailbox
Favorites
Boards
The Hangout
NASDAQ
NYSE
OTC Markets
All Boards
Whats Hot!
Recent Activity
Most Viewed Boards
Most Viewed Posts
Most Posted
Most Followed
Top Boards
Newest Boards
Newest Members
Blog
Recent Blog Posts
Recently Updated
News
Stocks
Crypto
Investing
Business
Markets
Economy
Real Estate
Personal Finance
Market Movers
Interactive Charts
Login - Join Now FREE!
Home
›
Stock Message Boards
›
Stock Boards
›
Innovation Pharmaceuticals Inc (IPIX) Message Board
Search
Search Type
Board
Post
Member
Hide Board Information
Show Board Information
Innovation Pharmaceuticals Inc IPIX
Board Mod:
Dynabolic
Asst Mods:
Kelt
Drano
NotRichYet2
Loose Lips
someconcerns
Mo
Last Post: 11/06/2024 9:48:45 AM
Board Marks: 278
Posts Today: 0
Board Views Today: 8986
Innovation Pharmaceuticals Inc. (IPIX)
Company Website:
http://www.ipharminc.com/
IPIX Stock Message Board Intro
Innovation Pharmaceuticals Inc (OTCMRKTS: IPIX) Stock Message Board
IPIX Company Profile
IPIX Time & Sales
IPIX Recent News
IPIX Filings
IPIX Financials
IPIX Buy Rating
Create New Post
View All Posts
Board Mark
Banned
Post
Subject
Author
Posted On
64595
Yesterdays PR was terrific. Brilacidin was found
(15)
farrell
05/20/2020 8:55:40 PM
70679
IPIX .. NR (non retail) would normally be showing
(16)
4kids
10/28/2021 12:32:05 PM
72046
Innovation Pharmaceuticals Announces Publication
(7)
Mo
10/04/2022 12:13:17 PM
72181
WAKEFIELD, MA / January 4, 2023 BT
(7)
Drano
01/09/2023 8:51:41 AM
69282
With all the discussion about SI, going on on the
(10)
Rip Van 03
04/19/2021 10:50:08 AM
69281
Clinical trail site updated
(3)
Patchesohoulihan
04/19/2021 10:47:59 AM
69280
Those that are short IPIX need to pony up as of
(5)
AlanC
04/19/2021 9:59:16 AM
69277
An interesting article -- "10 Signs your company
(9)
Drano
04/18/2021 5:23:13 PM
69274
$ IPIX $....Another great Brilacidin article
(3)
tryz
04/16/2021 5:12:36 PM
69273
I trust the Chinese Communist Party and all their
(6)
gchgch
04/16/2021 4:26:15 PM
69272
The 4,6-Pyrimidine dicarboxylic acid is an
farrell
04/16/2021 2:14:13 PM
69271
capacity to produce... tons" It is interesting
(4)
farrell
04/16/2021 2:11:29 PM
69270
Are they keeping the current B trial study from
NotRichYet2
04/16/2021 11:57:37 AM
69267
We are at war and we will win:
(6)
AlanC
04/16/2021 10:43:24 AM
69265
Brilacidin and more global exceptance as the
(3)
tryz
04/16/2021 5:36:44 AM
69263
Ridgeback and Merck halt molnupiravir trial for
(8)
farrell
04/15/2021 1:59:03 PM
69262
Merck pill failed.
(3)
Shry
04/15/2021 7:30:59 AM
69261
I'm a retired Batchelor with no dependents. I
(5)
gchgch
04/15/2021 12:29:14 AM
69255
Gotta love these quarter bargains. Thanks Shorty
(7)
scgmck1
04/14/2021 3:04:24 PM
69253
It is not the current human trial nor anything to
(7)
petemantx
04/14/2021 11:09:49 AM
69249
Innovation Pharmas Broad Spectrum Antiviral
bettingbig
04/14/2021 9:33:34 AM
69247
For those who want to learn more about the
(6)
AlanC
04/14/2021 9:12:32 AM
69242
I seem to have misunderstood the significance of
(7)
petemantx
04/12/2021 10:28:48 PM
69237
Time Stamps for the Mason Scientific Video. (
(7)
crashco
04/11/2021 5:43:00 PM
69236
I was impressed by Dr. Aarthi Naryana's pointed
(9)
crashco
04/11/2021 5:35:13 PM
69235
Agree Mo....this video to me is significant in
(8)
Chemdeps
04/11/2021 5:33:29 PM
69234
Rip Van 03, excellent video presentation. I am
(10)
Mo
04/11/2021 4:56:20 PM
69233
XOC (other board) posted start at 33:30 if you
(7)
Rip Van 03
04/11/2021 3:12:42 PM
69231
It is possible Brilacidin could be used for
(3)
farrell
04/11/2021 2:20:12 PM
69230
answering to Pete: Study protocol would have to
(1)
aragon1959
04/09/2021 5:44:13 PM
69226
Several of us here had ONTY. Because of potential
(14)
Drano
04/09/2021 2:55:21 PM
69225
I agree. Feuerstein is just a flash-basher and a
(6)
wildtp
04/09/2021 2:53:33 PM
69223
Drano said, Adam Feuerstein is an editor at
(10)
thefamilyman
04/09/2021 2:19:12 PM
69222
Have to hope that situations like that are few in
(1)
NotRichYet2
04/09/2021 12:53:45 PM
69221
If a patient in our trial goes downhill to the
(5)
petemantx
04/09/2021 12:38:36 PM
69219
Can Adam Feuerstein stop Russia or other
gchgch
04/09/2021 11:34:14 AM
69218
Adam Feuerstein is an editor at STATnews. I would
Drano
04/09/2021 11:25:04 AM
69216
A poster on the other board posted this article:
(1)
gchgch
04/09/2021 10:17:55 AM
69213
How's this for bullish speculation: When the
(8)
gchgch
04/09/2021 12:51:07 AM
69212
Patchesohoulihan Here's a great place to begin:
(1)
Rip Van 03
04/08/2021 1:08:29 PM
69210
Question about Mondays PR - it states in the
Patchesohoulihan
04/08/2021 11:50:44 AM
69208
This is interesting and hopefully will be used
(3)
AlanC
04/08/2021 9:55:07 AM
69206
The OTC is lawless
(3)
TMAN
04/08/2021 6:32:50 AM
69205
Dam shame no one here is a Reg' on WallStbets GME
2718
04/08/2021 5:13:29 AM
69203
Have been fighting abusive naked shorting for
(8)
AlanC
04/07/2021 7:24:40 PM
69202
I think the naked short no. is very likely double
(6)
TMAN
04/07/2021 6:18:59 PM
69200
One other VERY important factor I left out: Does
(14)
petemantx
04/07/2021 5:01:38 PM
69199
He has no evidence to support the opinion. It is
(2)
bandg
04/07/2021 4:59:15 PM
69198
What evidence do you have to make that opinion?
(2)
grotty
04/07/2021 4:33:59 PM
69196
I think the short is greater than the
(5)
AlanC
04/07/2021 4:03:31 PM
69194
https://www.pharmaceutical-technology.com/news/in
(2)
crashco
04/07/2021 1:58:25 PM
69192
I sent the following email to a couple of close
(12)
petemantx
04/07/2021 12:28:28 PM
69190
Absurd numbers. 100-200 million. Days to cover
grotty
04/07/2021 11:29:27 AM
69189
I'd add a third category -- people who know very
(4)
Drano
04/07/2021 11:16:12 AM
Newer
Older
Recent Articles
Central Garden & Pet Reports Q4 Earnings: Key Insights Revealed
Analyzing Woodward's Q4 Earnings and Future Outlook
Blue Bird's Financial Performance in the Latest Earnings Report
Central Garden & Pet Reports Strong Q4 Earnings Performance
Central Garden & Pet's Strong Q4 Earnings Highlights
Enanta Pharma's Earnings Report Highlights for Investors in 2024
Woodward Reports Strong Q4 Earnings, Offers Positive Guidance Ahead
Blue Bird's Fourth Quarter Earnings: Key Insights and Analysis
Leslie's Performance in Q4: Key Insights and Future Prospects
Exploring Central Garden & Pet's Recent Earnings Performance
Insights into Enanta Pharma's Q4 Earnings Performance
Blue Bird's Q4 Earnings Report Reveals Key Insights
NHTSA Stands Firm on New Emergency Braking Rule for Vehicles
Columbia Financial Appoints Matthew Smith as New COO
Impact of Treasury Picks on Markets and Emerging Economies
Market Reactions: Insights on Zoom, Agilent, HanesBrands, Kohl's
Zoom Communications Enhances Forecast Following Strong Q3 Results
Leadership Transition at Kohl's: Kingsbury's Departure Announced
Tempest Therapeutics to Showcase Innovations at Key Conference
Travere Therapeutics Announces Key Upcoming Investor Conferences
Tesla Stock Faces Market Challenges Amid California Proposals
Chegg Inc. Experience Stock Surge Following Debt Repurchase Deal
Zoom Communications Turns a Profit with Impressive Q3 Earnings
First Capital, Inc. Declares New Quarterly Dividend for Investors
Columbia Financial Welcomes New COO Matthew Smith Amid Changes
Universal Health Realty Income Trust Boosts Quarterly Dividend
Amazon Strengthens AI Alliances with Major Investment in Anthropic
Enanta Pharma's Q4 Earnings Exceed Expectations, Highlights Ahead
Woodward's Q4 Earnings Highlights and Future Outlook for Investors
Blue Bird's Q4 Earnings: Performance Review and Insights
Central Garden & Pet: Analyzing Quarterly Earnings Results
Central Garden & Pet Q4 Earnings Show Surprising Results
Semtech's Q3 Earnings Report Shows Promising Growth
LanzaTech Expands Board for Future Growth with Energy Expert
Zimmer Biomet Secures FDA Approval for Innovative Knee Implant
Remitly to Showcase Innovations at Upcoming TMT Summit
Dana Incorporates Leadership Change Amid Strategic Transformation
Lexicon Pharmaceuticals Announces Upcoming December Investor Events
Gaming and Leisure Properties, Inc. Announces Q4 2024 Dividend
NJR Clean Energy Ventures Finalizes $132.5 Million Solar Sale
ORIC Pharmaceuticals Enhances Visibility at December Conferences
LanzaTech Welcomes Thierry Pilenko to Board of Directors
Ant Group's IPO Collapse: Alibaba's Regulatory Struggles and Settlement Impact
EMP Metals Secures $3 Million Loan Agreement with Tembo
Leslies Experiences Financial Challenges in Latest Earnings
Dana Incorporates Strategic Changes to Boost Growth and Value
Fluence Energy Delivers Impressive Q4 Results and Growth Insights
StealthGas Reports Impressive Q3 Earnings Growth
Analyzing PennantPark Floating Rate's Q4 Earnings Results
Insights on Pennant Park Investment's Latest Earnings Report